CTOs on the Move

Envision Healthcare

www.evhc.net

 
Envision Healthcare, a leading national medical group, focused on investing in the future of health and wellness.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.evhc.net
  • 1A, Burton Hills Boulevard
    Nashville, TN USA 37215
  • Phone: 615.665.1283

Executives

Name Title Contact Details

Similar Companies

Autonomic Technologies

Welcome. Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company`s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache. The ATI Neurostimulation System was voted #2 among the Cleveland Clinic’s top 10 medical innovations for 2013, and Autonomic Technologies was named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device and diagnostics companies in the world.

BHcare

BHcare is a state-licensed, non-profit behavioral health care provider serving the Lower Naugatuck Valley, Greater New Haven, and Shoreline communities. For more than 30 years, BHcare – through its founding organizations, Birmingham Group Health Services and Harbor Health Services – has been providing hope and help for individuals, families and children affected by mental illness, domestic violence and substance abuse.

Bio Collections

Bio Collections is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

Supermed Inc

Supermed Inc is a Ormond Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.